2011
DOI: 10.1002/14651858.cd008871.pub2
|View full text |Cite
|
Sign up to set email alerts
|

Low-dose rate brachytherapy for men with localized prostate cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
12
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(12 citation statements)
references
References 434 publications
0
12
0
Order By: Relevance
“…Brachytherapy can provide local radiation delivery in or near tumors while potentially minimizing the adverse effects and toxicities (24). The response to brachytherapy is quite variable, with 5-year biochemical recurrence-free survival rates ranging from 71% to 96% (3, 4).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Brachytherapy can provide local radiation delivery in or near tumors while potentially minimizing the adverse effects and toxicities (24). The response to brachytherapy is quite variable, with 5-year biochemical recurrence-free survival rates ranging from 71% to 96% (3, 4).…”
Section: Introductionmentioning
confidence: 99%
“…The response to brachytherapy is quite variable, with 5-year biochemical recurrence-free survival rates ranging from 71% to 96% (3, 4). Preoperative nomograms from large studies (58) have helped improve risk stratification significantly.…”
Section: Introductionmentioning
confidence: 99%
“…There are many treatment modalities for prostate cancer including radical prostatectomy (Roehl et al , 2004), laparoscopic surgery (Touijer et al , 2009), three-dimensional (3D)-conformal radiotherapy (CRT) by photons (Zelefsky et al , 2008), intensity-modulated radiotherapy (IMRT) (Cahlon et al 2008), low-dose rate (LDR) brachytherapy (Peinemann et al , 2011), high-dose rate brachytherapy (Masson et al , 2012), proton beam therapy (Zietman et al , 2010), carbon ion radiotherapy (CIRT) (Ishikawa et al , 2006), hormone therapy (Souhami et al , 2009), and robot-assisted laparoscopic prostatectomy (Menon et al , 2010). A high dose of 78–80 Gy is generally used in 3D-CRT or IMRT for prostate cancer, and definitive radiotherapy using photons or proton beam requires ∼8 weeks (Zelefsky et al , 2008; Cahlon et al 2008; Zietman et al , 2010).…”
mentioning
confidence: 99%
“…The recently published Prostate Cancer Intervention Versus Observation Trial (PIVOT) — a randomised control trial comparing RP with watchful waiting in 731 US patients with localised prostate cancer disease — showed that RP was associated with reduced all‐cause mortality for men with a prostate‐specific antigen (PSA) level greater than 10 ng/mL but that it offered no survival benefit to men with a PSA level of 10 ng/mL or less 5 . A systematic review comparing disease‐free survival for low dose rate brachytherapy with other treatments for men with clinically localised prostate cancer found no significant difference when compared with RP 6 …”
mentioning
confidence: 99%